374 related articles for article (PubMed ID: 21214430)
1. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
3. Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration.
Nekkanti V; Venkateswarlu V; Ansari KA; Pillai R
Curr Drug Deliv; 2011 Nov; 8(6):661-6. PubMed ID: 22313161
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
5. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
8. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
Garnero C; Aiassa V; Longhi M
J Pharm Biomed Anal; 2012 Apr; 63():74-9. PubMed ID: 22361661
[TBL] [Abstract][Full Text] [Related]
9. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
10. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
13. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of a spray-dried hydroxypropyl-beta-cyclodextrin/quercetin complex.
Zheng Y; Chow AH
Drug Dev Ind Pharm; 2009 Jun; 35(6):727-34. PubMed ID: 19514988
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
16. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
[TBL] [Abstract][Full Text] [Related]
17. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin.
Yan Z; Xu W; Sun J; Liu X; Zhao Y; Sun Y; Zhang T; He Z
Drug Dev Ind Pharm; 2008 Jun; 34(6):632-41. PubMed ID: 18568914
[TBL] [Abstract][Full Text] [Related]
18. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
19. Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation.
Jiang Y; Sha X; Zhang W; Fang X
Int J Pharm; 2010 Sep; 397(1-2):116-21. PubMed ID: 20637848
[TBL] [Abstract][Full Text] [Related]
20. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
Garnero C; Zoppi A; Genovese D; Longhi M
Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]